Cipla share news, announcements and annual reports
NSE: CIPLABSE: 500087Pharmaceuticals & BiotechnologyLarge Cap
Cipla Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1983 on BSE, Feb 1995 on NSE
Last close ₹1,387.00up ₹8.10 (0.59%)BSE ₹1,382.00
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,378.90.
2 Nov: open ₹1,383.00, high ₹1,391.00, low ₹1,364.60
52-week range of traded prices to 2 Nov 2026
₹1,165.70Low, 2 Apr 2026₹1,539.70High, 6 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,12,052 Cr99th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.68
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.17
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.94%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,77,33662.2% delivered
Cipla share news and announcements
1,563 announcements, routine notices left out, newest first. Page 27 of 32.
Aug 2014
6 Aug · Board meeting
Inter alia, to consider and approve unaudited financial results for the quarter ended June 30, 2014. Further that in terms of Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading, the "trading window" for dealing in the securities of the company will remain closed from August 6, 2014 till completion of 24 hours after the unaudited financial results are made public.5 Aug · Meeting
Annual General Meeting of the Company will be held on September 3, 2014.5 Aug · Dividend
Dividend for the year ended March 31, 2014, subject to the approval of shareholders, will now be dispatched/ credited on or after September 8, 2014.
Jul 2014
Jun 2014
18 Jun · News Verification
News Verification : The media had reports that Cipla Limited "Corporate announcement on Cards.". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Cipla Limited has vide its letter inter-alia stated," This news item is purely baseless and speculative in nature."
May 2014
30 May · Dividend
Dividend, subject to the approval of shareholders will be dispatched/ credited on or after August 27, 2014.29 May · Meeting
Company has fixed Book Closure from August 8, 2014 to August 22, 2014 for the purpose of Annual General Meeting of the company is scheduled to be held on August 22, 2014 and determining the persons entitled for dividend for the year ended March 31, 2014.29 May · Dividend
Board of Directors of the Company at its meeting held on May 29, 2014 has recommended payment of dividend of Rs.2 per equity share (face value Rs.2) for the year 2013-14.8 May · News Verification
News Verification : The media had reports that "Teva woos Cipla with $6 billion offer" . The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Cipla Limited has vide its letter inter-alia stated,"This news item is purely baseless and speculative in nature.The claim in the news item of an offer made in November is incorrect and no such formal offer was received by the Cipla board. We have consistently denied such rumours in the past and continue to do so."
Apr 2014
Mar 2014
13 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 13, 2014, inter alia, has transacted the following items of business:- 1) Retirement of Mr. M. K. Hamied as Executive Vice-Chairman Mr. M. K. Hamied has expressed his desire to retire as Executive Vice-Chairman of the Company. The Board unanimously acknowledges the outstanding contribution of Mr. M. K. Hamied to the Company over the past 30 years, and in deference to his wishes, has accepted his proposal to retire as Executive Vice-Chairman effective March 31, 2014. Mr. M. K. Hamied however continues to be the Vice-Chairman of the Company in a non-executive role effective April 01, 2014. 2) Appointment of Mr. Rajesh Garg as Executive Director and Global Chief Financial Officer Mr. Rajesh Garg has been designated as "Executive Director and Global Chief Financial Officer" and appointed as an Additional Director and Whole-time Director of the Company with effect from April 01, 2014. Mr. Rajesh Garg joined the Company as its Global Chief Financial Officer on June 03, 2013.13 Mar · Management
Feb 2014
12 Feb · Management
Board of Directors at its meeting held on February 12, 2014 have appointed Dr. Peter Mugyenyi as an Additional Director with effect from February 12, 2014 to hold office as an Independent Director of the Company.4 Feb · Board meeting
Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2013 (Q3). Pursuant to the above and in terms of Company s Code of Internal Procedures and Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company will remain closed from 6:00 p.m. on February 04, 2014 till completion of 24 hours after the unaudited financial results are made public.
Dec 2013
5 Dec · Business
Cipla Holding B.V., a wholly owned subsidiary of the Company, has acquired 100% stake in Celeris d.o.o., Croatia. Celeris d.o.o. is the distributor of Company's products in Croatia.
Nov 2013
21 Nov · Updates
Meditab Holdings Limited ("MHL"), a wholly owned step down subsidiary of the Company, has acquired an additional 14.5% stake in Quality Chemical Industries Limited ("QCIL"), Uganda for a consideration of USD 15 million. QCIL's principal activity is manufacturing and selling of pharmaceutical drugs with emphasis on anti-retroviral (ARV's) and anti-malarial drugs. QCIL has a WHO approved manufacturing facility in Uganda. MHL was earlier holding 36.55% stake in QCIL. Consequent to the acquisition of aforesaid additional stake, MHL now holds 51.05% stake in QCIL.13 Nov · Results
Consolidated Results for the quarter ended on 30-SEP-2013 as follows: Net Sales of Rs. 246318 lacs for the quarter ending on 30-SEP-2013 against Rs. 230771 lacs for the quarter ending on 30-JUN-2013. Net Profit / (Loss) of of Rs. 35806 lacs for the quarter ending on 30-SEP-2013 against Rs. 48535 lacs for the quarter ending on 30-JUN-2013.13 Nov · Results
Standalone Results for the quarter ended on 30-SEP-2013 as follows: Net Sales of Rs. 230286 lacs for the quarter ending on 30-SEP-2013 against Rs. 228470 lacs and Rs. 214587 lacs for the quarters ending on 30-JUN-2013 and 30-SEP-2012 respectively. Net Profit / (Loss) of Rs. 37603 lacs for the quarter ending on 30-SEP-2013 against Rs. 47490 lacs and Rs. 50001 lacs for the quarters ending on 30-JUN-2013 and 30-SEP-2012 respectively.1 Nov · Board meeting
Inter-alia to consider Unaudited Financial Results for quarter and half year ended September 30, 2013.
Oct 2013
Sep 2013
25 Sep · Rating
India Ratings & Research Private Limited, a Fitch Group Company has assigned a Long-Term Issuer Rating of 'IND AAA' to the Company.